Correspondence

Advisory Council on the Misuse of drugs: Advice on O-desmethyltramadol (2012)

The ACMD have considered the harms associated with the use of O-desmethyltramadol and recommend that O-desmethyltramadol is controlled.

Documents

ACMD advice on O-desmethyltramadol (2012) (PDF file - 79kb)

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

O-desmethyltramadol is being offered for sale as a ‘legal high’ and has been identified as an undeclared ingredient of a ‘legal high’ product called ‘Krypton’. 

The ACMD have considered the harms associated with the use of O-desmethyltramadol and this correspondence recommends that O-desmethyltramadol is controlled under the Misuse of Drugs Act 1971.

Published 23 October 2012